Multi-detector row CT of the kidney: optimizing scan delays for bolus tracking techniques of arterial, corticomedullary, and nephrographic phases.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 17367973)

Published in Eur J Radiol on March 23, 2007

Authors

Satoshi Goshima1, Masayuki Kanematsu, Hironori Nishibori, Hiroshi Kondo, Yusuke Tsuge, Ryujiro Yokoyama, Toshiharu Miyoshi, Minoru Onozuka, Yoshimune Shiratori, Noriyuki Moriyama, Kyongtae T Bae

Author Affiliations

1: Department of Radiology, Gifu University School of Medicine, 1-1 Yanagido, Gifu 501-1193, Japan.

Articles by these authors

Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet (2003) 7.98

Volume progression in polycystic kidney disease. N Engl J Med (2006) 7.16

Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. Genome Res (2005) 5.22

Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med (2014) 5.01

Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Kidney Int (2003) 4.84

Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (2006) 2.21

Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol (2002) 2.18

Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Sci Transl Med (2011) 2.14

Detection and characterization of focal hepatic lesions with diffusion-weighted MR imaging: a pictorial review. Abdom Imaging (2013) 2.11

Diffusion-weighted MR imaging of the pancreas: current status and recommendations. Radiology (2015) 2.11

Chest wall tumors: radiologic findings and pathologic correlation: part 2. Malignant tumors. Radiographics (2003) 2.06

Total and intraabdominal fat distribution in preadolescents and adolescents: measurement with MR imaging. Radiology (2007) 1.92

Chest wall tumors: radiologic findings and pathologic correlation: part 1. Benign tumors. Radiographics (2003) 1.82

Therapeutic effect of intraarterial prednisolone injection in severe intestinal Behçet's disease. J Gastroenterol (2002) 1.63

Differential renal function estimation using computerized tomography based renal parenchymal volume measurement. J Urol (2010) 1.62

The HALT polycystic kidney disease trials: design and implementation. Clin J Am Soc Nephrol (2010) 1.59

Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome. Kidney Int (2008) 1.58

Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning. Int J Radiat Oncol Biol Phys (2010) 1.58

Volumetric measurement of synthetic lung nodules with multi-detector row CT: effect of various image reconstruction parameters and segmentation thresholds on measurement accuracy. Radiology (2005) 1.54

Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2006) 1.53

High frequency of calcification in basal ganglia on brain computed tomography images in Japanese older adults. Geriatr Gerontol Int (2012) 1.49

Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP). Am J Kidney Dis (2005) 1.49

Coronary artery calcium: accuracy and reproducibility of measurements with multi-detector row CT--assessment of effects of different thresholds and quantification methods. Radiology (2003) 1.45

Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease. Kidney Int (2003) 1.45

Automated matching of pulmonary nodules: evaluation in serial screening chest CT. AJR Am J Roentgenol (2009) 1.44

Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study. Am J Kidney Dis (2011) 1.39

Validation of CT dose-reduction simulation. Med Phys (2009) 1.38

Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohort. J Am Soc Nephrol (2006) 1.37

Computer-aided diagnosis of localized ground-glass opacity in the lung at CT: initial experience. Radiology (2005) 1.36

Diffusion-weighted imaging of the liver: optimizing b value for the detection and characterization of benign and malignant hepatic lesions. J Magn Reson Imaging (2008) 1.32

Primary dedifferentiated liposarcoma of the retroperitoneum. Prognostic significance of computed tomography and magnetic resonance imaging features. J Comput Assist Tomogr (2003) 1.32

Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations. Radiology (2011) 1.31

Synovial sarcoma of the soft tissues: prognostic significance of imaging features. J Comput Assist Tomogr (2004) 1.31

Metastatic angiosarcoma of the lung: spectrum of CT findings. AJR Am J Roentgenol (2003) 1.26

Effects of CT section thickness and reconstruction kernel on emphysema quantification relationship to the magnitude of the CT emphysema index. Acad Radiol (2010) 1.26

Gastrointestinal stromal tumor. Correlation of computed tomography findings with tumor grade and mortality. J Comput Assist Tomogr (2003) 1.24

Desmoplastic small round cell tumor: imaging findings associated with clinicopathologic features. J Comput Assist Tomogr (2002) 1.22

Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2010) 1.21

Contrast enhancement in cardiovascular MDCT: effect of body weight, height, body surface area, body mass index, and obesity. AJR Am J Roentgenol (2008) 1.17

Evidence of extraordinary growth in the progressive enlargement of renal cysts. Clin J Am Soc Nephrol (2010) 1.16

Accuracy of high-resolution magnetic resonance imaging in preoperative staging of rectal cancer. Ann Surg Oncol (2009) 1.15

Contrast-enhanced dynamic computed tomography for the evaluation of tumor angiogenesis in patients with lung carcinoma. Cancer (2002) 1.15

Xanthogranulomatous cholecystitis: diagnostic performance of CT to differentiate from gallbladder cancer. Eur J Radiol (2009) 1.14

Primary leiomyosarcoma of the pulmonary artery: a diagnostic dilemma. Clin Imaging (2003) 1.14

Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer. J Comput Assist Tomogr (2004) 1.13

Spontaneous dissection of the superior mesenteric artery diagnosed on multidetector helical CT. J Comput Assist Tomogr (2002) 1.13

Spectrum of MRI appearances of untreated metastases of the liver. AJR Am J Roentgenol (2003) 1.13

Computer-aided diagnosis of hepatic fibrosis: preliminary evaluation of MRI texture analysis using the finite difference method and an artificial neural network. AJR Am J Roentgenol (2007) 1.13

Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study. PLoS One (2013) 1.12

Evaluation of organ involvement in intravascular large B-cell lymphoma by 18F-fluorodeoxyglucose positron emission tomography. Int J Hematol (2008) 1.11

Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study. Intervirology (2008) 1.10

Comparison of standard- and low-radiation-dose CT for quantification of emphysema. AJR Am J Roentgenol (2007) 1.10

Automatic segmentation and recognition of anatomical lung structures from high-resolution chest CT images. Comput Med Imaging Graph (2006) 1.09

Computerized scheme for assessing ultrasonographic features of breast masses. Acad Radiol (2005) 1.09

Coronary artery calcification and risk factors for atherosclerosis in patients with venous thromboembolism. Atherosclerosis (2005) 1.07

Volvulus of the gall bladder diagnosed by ultrasonography, computed tomography, coronal magnetic resonance imaging and magnetic resonance cholangio-pancreatography. World J Gastroenterol (2006) 1.06

Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. Updated analysis of the long-term follow-up data. Intervirology (2005) 1.04

High-intensity signal on time-of-flight magnetic resonance angiography indicates carotid plaques at high risk for cerebral embolism during stenting. Stroke (2011) 1.04

Effect of edema on postimplant dosimetry in prostate brachytherapy using CT/MRI fusion. Int J Radiat Oncol Biol Phys (2007) 1.03

Visceral fat volume and the prevalence of colorectal adenoma. Am J Epidemiol (2009) 1.03

Preoperative detection of prostate cancer: a comparison with 11C-choline PET, 18F-fluorodeoxyglucose PET and MR imaging. J Magn Reson Imaging (2010) 1.02

Test-bolus versus bolus-tracking techniques for CT angiographic timing. Radiology (2005) 1.02

Diffusion-weighted single shot echo planar imaging of colorectal cancer using a sensitivity-encoding technique. Jpn J Clin Oncol (2004) 1.01

Alterations in thigh subcutaneous adipose tissue gene expression in protease inhibitor-based highly active antiretroviral therapy. Metabolism (2005) 1.00

Pancreas: optimal scan delay for contrast-enhanced multi-detector row CT. Radiology (2006) 1.00

Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography: a preliminary report. Ann Nucl Med (2008) 1.00

Diffusion/perfusion MR imaging of the liver: practice, challenges, and future. Magn Reson Med Sci (2012) 1.00

Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator? J Magn Reson Imaging (2008) 1.00

Clinical significance of serum HGF and c-Met expression in tumor tissue for evaluation of properties and treatment of hepatocellular carcinoma. Hepatogastroenterology (2008) 1.00